Skip to main content

Table 4 Prescription cost per patient-year for all diabetes-related medications (€PY)

From: Management of type 2 diabetes and its prescription drug cost before and during the economic crisis in Greece: an observational study

  2006 2012 p
Glucose-lowering (all patients) 390.7 [363.5-418.0] 612.4 [586.5-638.2] < 0.001
Glucose-lowering (only treated patients) 405.3 [377.6-433.1] 621.1 [595.1-647.1] < 0.001
 OAD only 324.9 [297.0-352.9] 504.5 [476.3-532.7] < 0.001
 Insulin 553.8 [501.6-606.0] 763.8 [720.6-807.0] < 0.001
 Excluding incretins 405.3 [501.6-606.0] 508.0 [474.7-541.3] < 0.001
 Excluding incretins & adjusting for insulin analog use 442.4 [415.2-469.6] 463.2 [431.5-495.0] 0.34
Antihypertensive (all patients) 285.3 [270.6-300.1] 255.2 [241.1-269.2] 0.004
Antihypertensive (only treated patients) 371.5 [356.0-387.1] 318.7 [304.7-332.7] < 0.001
Lipid-lowering (all patients) 357.3 [335.0-379.5] 361.0 [339.9-382.1] 0.81
Lipid-lowering (only treated patients) 571.8 [547.2-596.4] 449.9 [429.5-450.3] < 0.001
Antiplatelet (all patients) 89.0 [75.8-102.1] 78.1 [65.6-90.7] 0.25
Antiplatelet (only treated patients) 169.8 [146.2-193.4] 146.4 [124.2-168.5] 0.16
Total 1122.3 [1078.1-1166.5] 1306.7 [1264.6-1348.7] < 0.001
  1. Data are shown as mean [95% CI]. Treated patients are considered as those receiving the respective class of medication. All comparisons have been adjusted for age and duration of diabetes.